Interactive guidance therapy with video feedback for parents and children with autism
Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder
This study is testing a new therapy that uses video feedback to help parents improve their interactions with their young children who have autism.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Months to 3 Years |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 4 sites (Montpellier and 3 other locations) |
| Trial ID | NCT04607616 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Interactive Guidance Therapy (IGT) that incorporates video feedback for parents and their children diagnosed with Autism Spectrum Disorder (ASD) under three years of age. Utilizing a Single Case Experimental Design, the study aims to enhance parental sensitivity and interaction skills through real-time analysis of parent-child interactions. The approach is based on established methods that have shown positive outcomes in improving communication and reducing autistic symptoms. The study is multicentric and randomized, ensuring a robust assessment of the therapy's impact.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 18 months to 3 years diagnosed with Autism Spectrum Disorder or pervasive developmental disorder, along with their primary caregivers.
Not a fit: Patients who may not benefit from this study include those with severe sensory impairments or parents who cannot communicate effectively in French.
Why it matters
Potential benefit: If successful, this therapy could significantly improve parent-child interactions and reduce symptoms of autism in young children.
How similar studies have performed: Previous studies using video feedback methods have shown moderate to long-term positive effects on parent-child interactions, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 months to 3 years child at screening * Child with a diagnosis of Autism Spectrum Disorder (DSM 5) or pervasive Developmental Disorder (ICD 10) * Child with ADI R and ADOS-2 fulfilling the criteria for TSA / PDD at diagnosis * Developmental age \> 12 months in motility with the Brunet-Lézine test * Child with availability of parent most present in daily life, only this parent participating directly in play sessions * Signed Informed consent form by both parents * Patient affiliated to the health insurance system Exclusion Criteria: * Level of language in French of parents insufficient to benefit from the care and fill in the questionnaires * Psychiatric parental pathology interfering with interactions with the child, qualitatively assessed by the referring psychiatrist * Severe sensory illness of the child (blindness, deafness, degenerative disease)
Where this trial is running
Montpellier and 3 other locations
- Hôpital Saint Eloi — Montpellier, France (Recruiting)
- Hôpital Ville Evrard — Montreuil, France (Recruiting)
- Hôpital Pitié Salpétriere — Paris, France (Recruiting)
- Hôpital Necker Enfants Malades — Paris, France (Recruiting)
Study contacts
- Study coordinator: Lisa OUSS, MD
- Email: lisa.ouss@aphp.fr
- Phone: +33 1 44 49 45 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.